Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers-Reference-Cited by-同舟云学术

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers

Published:2015-09-30 Issue:34 Volume:6 Page:35737-35754
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Mehner Christine¹,Oberg Ann L.²,Kalli Kimberly R.³,Nassar Aziza⁴,Hockla Alexandra¹,Pendlebury Devon¹,Cichon Magdalena A.¹,Goergen Krista M.²,Maurer Matthew J.²,Goode Ellen L.⁵,Keeney Gary L.⁶,Jatoi Aminah³,Sahin-Tóth Miklós⁷,Copland John A.¹,Radisky Derek C.¹,Radisky Evette S.¹

Affiliation:

1. Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA

2. Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA

3. Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA

4. Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL, USA

5. Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA

6. Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

7. Department of Molecular and Cell Biology, Boston University Henry M. Goldman School of Dental Medicine, Boston, MA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting anoikis resistance as a strategy for cancer therapy;Drug Resistance Updates;2024-07

2. Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models;International Journal of Clinical Oncology;2024-05-20

3. Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis;2024-05-08

4. Development of an Anoikis-Related Gene Signature for Lung Squamous Cell Carcinomato Predict Prognosis, Immune Landscape, and Immunotherapy Response;Journal of Immunology Research;2023-12-09

5. Development of an anoikis-related gene signature for lung squamous cell carcinoma to predict prognosis, immune landscape, and immunotherapy response;2023-07-03